Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER2/neu-Overexpressing Breast Tumor Xenografts
暂无分享,去创建一个
S. Hilsenbeck | R. Schiff | G. Arpino | Meng-Fen Wu | I. Migliaccio | C. Gutierrez | M. Rimawi | L. Wiechmann | S. Massarweh | C. Osborne | Yen-chao Wang | R. Soliz | Catherine Huang | R. Ward | Lisa S. Wiechmann | C. Kent Osborne